Lucintel's latest market report analyzed that hospital acquired disease testing provides attractive opportunities in hospitals and intensive care units (ICUS). The Hospital acquired disease testing market is expected to grow with a CAGR of 14%-16%. In this market, urinary tract infection is the largest segment by test type, whereas hospitals and intensive care units (ICUs) is largest by end user.
Download Brochure of this report by clicking on https://www.lucintel.com/hospital-acquired-disease-testing-market.aspx

Based on test type, the hospital acquired disease testing market is segmented into urinary tract infection, surgical site infection, pneumonia stents, blood stream infection, and methicillin-resistant staphylococcus aureus. The urinary tract infection segment accounted for the largest share of the market in 2020 and is expected to register the highest CAGR during the forecast period, due to high prevalence of hospital acquired infections and increasingly popular techniques that are being used for preventing, diagnosing, & treating the hospital-associated infections, such as polymerise chain reaction (PCR), solid-phase hybridization, and microarrays.
Browse in-depth TOC on “Hospital Acquired Disease Testing Market”
XX – Tables
XX – Figures
150 – Pages
The Hospital Acquired Disease Testing Market is marked by the presence of several big and small players. Some of the prominent players offering hospital acquired disease testing include Diatherix Corp, Roche, Cantel Medical Corporation, Qiagen, and Cephid, bioMeriux.
Request Sample Report:
https://www.lucintel.com/hospital-acquired-disease-testing-market.aspx

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. 972.636.5056
Cell: 303.775.0751
Related reports
Healthcare IT Market:
For more details click here https://www.lucintel.com/healthcare-it-market.aspx

Medical Holography Market:
For more details click here https://www.lucintel.com/medical-holography-market.aspx

Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx

Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx

Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/opportunities-in-the-industrial-microbiologycolonopt-size,-trends-and-growth-analysis.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx